MYXOID PLEOMORPHIC LIPOSARCOMA

Clinical trials for MYXOID PLEOMORPHIC LIPOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new MYXOID PLEOMORPHIC LIPOSARCOMA trials appear

Sign up with your email to follow new studies for MYXOID PLEOMORPHIC LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug duo targets Tough-to-Treat fat tissue cancer

Disease control Recruiting now

This study is testing whether combining two drugs, mirdametinib and palbociclib, can help control advanced liposarcoma, a type of cancer that starts in fat tissue. Researchers will first find the safest dose of the combination, then see if it can keep the cancer from growing for …

Matched conditions: MYXOID PLEOMORPHIC LIPOSARCOMA

Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

MYXOID PLEOMORPHIC LIPOSARCOMA

Get alerted when new MYXOID PLEOMORPHIC LIPOSARCOMA trials appear

New drug duo targets Tough-to-Treat fat tissue cancer